88 related articles for article (PubMed ID: 38578040)
21. Outbreak detection algorithms based on generalized linear model: a review with new practical examples.
Zareie B; Poorolajal J; Roshani A; Karami M
BMC Med Res Methodol; 2023 Oct; 23(1):235. PubMed ID: 37838735
[TBL] [Abstract][Full Text] [Related]
22. NOD-like Receptor Signaling Pathway in Gastrointestinal Inflammatory Diseases and Cancers.
Zhou Y; Yu S; Zhang W
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833958
[TBL] [Abstract][Full Text] [Related]
23. Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management.
Garcia-Manero G
Am J Hematol; 2023 Aug; 98(8):1307-1325. PubMed ID: 37288607
[TBL] [Abstract][Full Text] [Related]
24. Early-Life Gut Microbiota Governs Susceptibility to Colitis via Microbial-Derived Ether Lipids.
Liu Y; Jiao C; Zhang T; Li X; Li P; Lu M; Ye Z; Du Y; Du R; Zhang W; Xu J; Zheng Z; Xu Y; Xue C; Zhang Y; Liu Y
Research (Wash D C); 2023; 6():0037. PubMed ID: 37040489
[TBL] [Abstract][Full Text] [Related]
25. A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma.
Gao D; Liu R; Lv Y; Feng Y; Hong F; Xu X; Hu J; He A; Yang Y
Front Oncol; 2023; 13():999688. PubMed ID: 36845727
[TBL] [Abstract][Full Text] [Related]
26. Myelodysplastic syndromes.
Li H; Hu F; Gale RP; Sekeres MA; Liang Y
Nat Rev Dis Primers; 2022 Nov; 8(1):74. PubMed ID: 36396662
[TBL] [Abstract][Full Text] [Related]
27. Integrated assessment of the clinical and biological value of ferroptosis-related genes in multiple myeloma.
Fu B; Shao R; Wang H; Chen G; Bai S; Wang H
Cancer Cell Int; 2022 Oct; 22(1):326. PubMed ID: 36274128
[TBL] [Abstract][Full Text] [Related]
28. From iron chelation to overload as a therapeutic strategy to induce ferroptosis in hematologic malignancies.
Li J; Zhang W
Hematology; 2022 Dec; 27(1):1163-1170. PubMed ID: 36222350
[TBL] [Abstract][Full Text] [Related]
29. The yin-yang of immunity: Immune dysregulation in myelodysplastic syndrome with different risk stratification.
Peng X; Zhu X; Di T; Tang F; Guo X; Liu Y; Bai J; Li Y; Li L; Zhang L
Front Immunol; 2022; 13():994053. PubMed ID: 36211357
[TBL] [Abstract][Full Text] [Related]
30. Integrative analysis of enrichment and prognostic value of ferroptosis-related genes and pathways in multiple myeloma.
Su Q; Li Q; Zhang W; Li B; Zhuang W
Carcinogenesis; 2022 Dec; 43(11):1050-1058. PubMed ID: 36170154
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and Treatment of Myelodysplastic Syndromes: A Review.
Sekeres MA; Taylor J
JAMA; 2022 Sep; 328(9):872-880. PubMed ID: 36066514
[TBL] [Abstract][Full Text] [Related]
32. Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer.
Wu S; Pan R; Lu J; Wu X; Xie J; Tang H; Li X
Front Oncol; 2022; 12():896927. PubMed ID: 35719954
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Analysis of a Ferroptosis Pattern and Associated Prognostic Signature in Acute Myeloid Leukemia.
Cui Z; Fu Y; Yang Z; Gao Z; Feng H; Zhou M; Zhang L; Chen C
Front Pharmacol; 2022; 13():866325. PubMed ID: 35656299
[TBL] [Abstract][Full Text] [Related]
34. N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer.
Zou Y; Zheng S; Xie X; Ye F; Hu X; Tian Z; Yan SM; Yang L; Kong Y; Tang Y; Tian W; Xie J; Deng X; Zeng Y; Chen ZS; Tang H; Xie X
Nat Commun; 2022 May; 13(1):2672. PubMed ID: 35562334
[TBL] [Abstract][Full Text] [Related]
35. Identify DNA-Binding Proteins Through the Extreme Gradient Boosting Algorithm.
Zhao Z; Yang W; Zhai Y; Liang Y; Zhao Y
Front Genet; 2021; 12():821996. PubMed ID: 35154264
[TBL] [Abstract][Full Text] [Related]
36. NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.
Greenberg PL; Stone RM; Al-Kali A; Bennett JM; Borate U; Brunner AM; Chai-Ho W; Curtin P; de Castro CM; Deeg HJ; DeZern AE; Dinner S; Foucar C; Gaensler K; Garcia-Manero G; Griffiths EA; Head D; Jonas BA; Keel S; Madanat Y; Maness LJ; Mangan J; McCurdy S; McMahon C; Patel B; Reddy VV; Sallman DA; Shallis R; Shami PJ; Thota S; Varshavsky-Yanovsky AN; Westervelt P; Hollinger E; Shead DA; Hochstetler C
J Natl Compr Canc Netw; 2022 Feb; 20(2):106-117. PubMed ID: 35130502
[TBL] [Abstract][Full Text] [Related]
37. Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia.
Wang J; Zhuo Z; Wang Y; Yang S; Chen J; Wang Y; Geng S; Li M; Du X; Lai P; Weng J
Front Cell Dev Biol; 2021; 9():800267. PubMed ID: 35127715
[No Abstract] [Full Text] [Related]
38. Construction and Validation of a Novel Ferroptosis-Related Prognostic Model for Acute Myeloid Leukemia.
Song Y; Tian S; Zhang P; Zhang N; Shen Y; Deng J
Front Genet; 2021; 12():708699. PubMed ID: 35111195
[TBL] [Abstract][Full Text] [Related]
39. Ferroptosis Markers Predict the Survival, Immune Infiltration, and Ibrutinib Resistance of Diffuse Large B cell Lymphoma.
Weng J; Chen L; Liu H; Yang XP; Huang L
Inflammation; 2022 Jun; 45(3):1146-1161. PubMed ID: 35064379
[TBL] [Abstract][Full Text] [Related]
40. Construction and validation of a risk scoring model for diffuse large B-cell lymphoma based on ferroptosis-related genes and its association with immune infiltration.
Xiong D; Li M; Zeng C
Transl Oncol; 2022 Feb; 16():101314. PubMed ID: 34920339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
